Unlike ALK, there are several mechanisms of resistance that have been reported in EGFR-expressing lung cancer cells and BCR-ABL (breakpoint cluster region-abelson)-expressing chronic myeloid leukemia (CML) cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.